Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials
Oragenics Inc. (NYSE American: OGEN), a biotechnology firm specializing in intranasal therapeutics for brain-related co
Miami, Florida — August 6, 2026, Evertise AI PR, The U.S. Minority Chamber of Commerce (USMCC) is honored to announce the...
Nuclear Emergency Preparedness: “The Challenges and Assistance Required Following a Nuclear Attack” Miami, Florida – Aug 6, 2026, Evertise AI...
Curated Back-to-School Shopping Guide Combines Cutting-Edge Technology and Hands-On Learning Tools to Boost Student Productivity and Confidence West Palm Beach,...
Oragenics Inc. (NYSE American: OGEN), a biotechnology firm specializing in intranasal therapeutics for brain-related co
Oragenics Inc. (NYSE American: OGEN), a biotechnology firm specializing in intranasal therapeutics for brain-related co
TBC Uzbekistan has been acknowledged as one of the world's leading fintech companies in the neobanking category
TBC Uzbekistan has been acknowledged as one of the world's leading fintech companies in the neobanking category
TBC Uzbekistan has been acknowledged as one of the world's leading fintech companies in the neobanking category
A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that th
A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that th
A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that th
NanoViricides, Inc. (NYSE American: NNVC), a leader in the development of host-mimetic nanomedicine, has reaffirme
NanoViricides, Inc. (NYSE American: NNVC), a leader in the development of host-mimetic nanomedicine, has reaffirme
NanoViricides, Inc. (NYSE American: NNVC), a leader in the development of host-mimetic nanomedicine, has reaffirme
Dot Ai, a Nasdaq-listed IoT and AI-based SaaS startup, has announced the limited availability of its ZiM Bridge,